Meloxicam IV/IM
Meloxicam IV/IM. An aqueous extended-release formulation of the selective COX-2 inhibitor non-steroidal anti-inflammatory drug meloxicam that has been developed by APIL using NanoCrystal Technology, including an intravenous or intramuscular form existing as of the Effective Date.
All Definitions
Found in
Recro Pharma, Inc. contract